1. Home
  2. PRTC vs FFWM Comparison

PRTC vs FFWM Comparison

Compare PRTC & FFWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • FFWM
  • Stock Information
  • Founded
  • PRTC 2015
  • FFWM 1990
  • Country
  • PRTC United States
  • FFWM United States
  • Employees
  • PRTC N/A
  • FFWM N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • FFWM Major Banks
  • Sector
  • PRTC Health Care
  • FFWM Finance
  • Exchange
  • PRTC Nasdaq
  • FFWM Nasdaq
  • Market Cap
  • PRTC 439.8M
  • FFWM 378.0M
  • IPO Year
  • PRTC N/A
  • FFWM 2014
  • Fundamental
  • Price
  • PRTC N/A
  • FFWM $5.60
  • Analyst Decision
  • PRTC Buy
  • FFWM Buy
  • Analyst Count
  • PRTC 1
  • FFWM 4
  • Target Price
  • PRTC $45.00
  • FFWM $7.25
  • AVG Volume (30 Days)
  • PRTC 5.9K
  • FFWM 690.8K
  • Earning Date
  • PRTC 08-27-2025
  • FFWM 07-31-2025
  • Dividend Yield
  • PRTC N/A
  • FFWM N/A
  • EPS Growth
  • PRTC N/A
  • FFWM N/A
  • EPS
  • PRTC 0.21
  • FFWM N/A
  • Revenue
  • PRTC $4,828,000.00
  • FFWM $113,564,000.00
  • Revenue This Year
  • PRTC $35.98
  • FFWM $182.35
  • Revenue Next Year
  • PRTC $115.38
  • FFWM $7.79
  • P/E Ratio
  • PRTC $7.93
  • FFWM N/A
  • Revenue Growth
  • PRTC 44.98
  • FFWM N/A
  • 52 Week Low
  • PRTC $13.30
  • FFWM $4.42
  • 52 Week High
  • PRTC $25.00
  • FFWM $8.52
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 43.39
  • FFWM 64.36
  • Support Level
  • PRTC $16.50
  • FFWM $5.04
  • Resistance Level
  • PRTC $18.40
  • FFWM $5.65
  • Average True Range (ATR)
  • PRTC 0.45
  • FFWM 0.20
  • MACD
  • PRTC -0.17
  • FFWM 0.05
  • Stochastic Oscillator
  • PRTC 20.88
  • FFWM 97.01

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

About FFWM First Foundation Inc.

First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.

Share on Social Networks: